Quantitative human health risk assessment for 1,3-butadiene based upon ovarian effects in rodents

Regulatory Toxicology and Pharmacology

Volumn 62, Issue 2, 2012, Pages 371-384

  Kirman, C R ^a   Grant, R L ^b  

^a LLP   (United States)

^b Texas Commission on Environmental Quality   (United States)

Author keywords

1,3 Butadiene; Meta analysis; Noncancer risk assessment; Ovarian follicles; Reference concentration

Indexed keywords

1,3 BUTADIENE;

ARTICLE; CASE STUDY; CELL COUNT; CONCENTRATION RESPONSE; DETOXIFICATION; EARLY MENOPAUSE; EXPOSURE; HEALTH HAZARD; HUMAN; MATHEMATICAL MODEL; NONHUMAN; OVARY ATROPHY; OVARY DISEASE; OVARY FOLLICLE MATURATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; REPRODUCTIVE TOXICITY; RESPONSE TIME; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICOKINETICS;

ADULT; ANIMALS; BUTADIENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MICE; MIDDLE AGED; OVARY; RATS; RISK ASSESSMENT;

MUS; RATTUS; RODENTIA;

EID: 84857366799     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.11.001     Document Type: Article

References (76)

1. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Wright M., Nicklas J.A., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B. Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem. Biol. Interact. 2001, 135-136:429-453.
2. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Nicklas J.A., van Sittert N.J., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B., Wright M., et al. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. HEI Res. Rep. 2003, 116:1-141.
3. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Rossner P., Nicklas J.A., McDonald J.D., Boysen G., Georgieva N., Swenberg J.A. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons. Chem. Biol. Interact. 2007, 166(1-3):63-77.
4. Appt S.E., Kaplan J.R., Clarkson T.B., Cline J.M., Christian P.J., Hoyer P.B. Destruction of primordial ovarian follicles in adult cynomolgus macaques after exposure to 4-vinylcyclohexene diepoxide: a nonhuman primate model of the menopausal transition. Fertil. Steril. 2006, 86(4 Suppl.):1210-1216.
5. Begemann P., Sram R.J., Neumann H.G. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene. Arch. Toxicol. 2001, 74(11):680-687.
6. Bergmark E., Calleman C.J., He F., Costa L.G. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol. 1993, 120:45-54.
7. Bevan C., Stadler J.C., Elliott G.S., Frame S.R., Baldwin J.K., Leung H.W., Moran E., Panepinto A.S. Subchronic toxicity of 4-vinylcyclohexene in rats and mice by inhalation exposure. Fundam. Appl. Toxicol. 1996, 32(1):1-10.
8. Bond J.A., Dahl A.R., Henderson R.F., Birnbaum L.S. Species differences in the distribution of inhaled butadiene in tissues. Am. Ind. Hyg. Assoc. J. 1987, 48(10):867-872.
9. Bond J.A., Csanády G.A., Leavens T., Medinsky M.A. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans. IARC Sci. Publ. 1993, (127):45-55.
10. Boobis A.R., Doe J.E., Heinrich-Hirsh B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 2008, 38:87-96.
11. Boysen G., Georgieva N.I., Upton P.B., Jayaraj K., Li Y., Walker V.E., Swenberg J.A. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene. Cancer Res. 2004, 64(23):8517-8520.
12. Brochot C., Smith T.J., Bois F.Y. Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues. Chem. Biol. Interact. 2007, 167(3):168-183.
13. Cheng H., Sathiakumar N., Graff J., Matthews R., Delzell E. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships. Chem. Biol. Interact. 2007, 166:15-24.
14. Crump K.S., Chiu W.A., Subramaniam R.P. Issues in using human variability distributions to estimate low-dose risk. Environ. Health Perspect. 2010, 118(3):387-393.
15. Csanady G.A., Guengerich F.P., Bond J.A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 1992, 13(7):1143-1153.
16. Csanady G.A., Kreuzer P.E., Baur C., Filser J.G. A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts - relevance of glutathione depletion. Toxicology 1996, 113(1-3):300-305.
17. Curren K.C., Dann T.F., Wang D.K. Ambient air 1,3-butadiene concentrations in Canada (1995-2003): seasonal, day of week variations, trends, and source influences. Atmos. Environ. 2006, 40:170-181.
18. Delzell E., Sathiakumar N., Graff J., Macaluso M., Maldonado G., Matthew R. An updated study of mortality among North American synthetic rubber industry workers. Health Effects Inst. 2006, 132.
19. Derelanko M.J. Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method. Fundam. Appl. Toxicol. 1987, 9(2):271-276.
20. Doerr J.K., Hollis E.A., Sipes I.G. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Toxicology 1996, 113(1-3):128-136.
21. Doerr J.K., Hooser S.B., Smith B.J., Sipes I.G. Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: role of diepoxides. Chem. Res. Toxicol. 1995, 8(7):963-969.
22. Duescher R.J., Elfarra A.A. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch. Biochem. Biophys. 1994, 311(2):342-349.
23. Filser J.G., Bhowmik S., Faller T.H., Hutzler C., Kessler W., Midpanon S., Pütz C., Schuster A., Semder B., Veereshwarayya V., Csanády G.A. Quantitative investigation on the metabolism of 1,3-butadiene and of its oxidized metabolites in once-through perfused livers of mice and rats. Toxicol. Sci. 2010, 114(1):25-37.
24. Filser J.G., Faller T.H., Bhowmik S., Schuster A., Kessler W., Pütz C., Csanády G.A. First-pass metabolism of 1,3-butadiene in once-through perfused livers of rats and mice. Chem. Biol. Interact. 2001, 135-136:249-265.
25. Filser J.G., Hutzler C., Meischner V., Veereshwarayya V., Csanády G.A. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats. Chem. Biol. Interact. 2007, 166(1-3):93-103.
26. Fred C., Kautiainen A., Athanassiadis I., Tornqvist M. 2004. Hemoglobin adduct levels in rat and mouse treated with 1,2:3,4-diepoxybutane. Chem. Res. Toxicol. 2004, 17:785-794.
27. Fustinoni S., Soleo L., Warholm M., Begemann P., Rannug A., Neumann H.G., Swenberg J.A., Vimercati L., Colombi A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1082-1090.
28. Fustinoni S., Perbellini L., Soleo L., Manno M., Foà V. Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol. Lett. 2004, 149(1-3):353-360.
29. Georgieva N.I., Boysen G., Bordeerat N., Walker V.E., Swenberg J.A. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene. Toxicol. Sci. 2010, 115(2):322-329. (Epub 2010 Feb 22).
30. Graham L.A., Noseworthy L., Fugler D., O'Leary K., Karman D., Grande C. Contribution of vehicle emissions from an attached garage to residential indoor air pollution levels. J. Air Waste Manag. Assoc. 2004, 54(5):563-584.
31. Grant R.L., Leopold V., McCant D., Honeycut M. Spatial and temporal trend evaluation of ambient concentrations of 1,3-butadiene and chloroprene in Texas. Chem. Biol. Interact. 2007, 166(1-3):44-51.
32. Grant R.L., Haney J., Curry A.L., Honeycutt M. A chronic reference value for 1,3-butadiene based on an updated noncancer toxicity assessment. J. Toxicol. Environ. Health B 2010, 13:460-475.
33. Graff J.J., Sathiakumar N., Macaluso M., Maldonado G., Matthews R., Delzell E. Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. J. Occup. Environ. Med. 2005, 47:916-932.
34. Gustafson P., Barregard L., Strandberg B., Sallsten G. The impact of domestic wood burning on personal, indoor and outdoor levels of 1,3-butadiene, benzene, formaldehyde and acetaldehyde. J. Environ. Monitor. 2007, 9(1):23-32.
35. Hayes R.B., Xi L., Bechtold W.E., Rothman N., Yao M., Henderson R., Zhang L., Smith M.T., Zhang D., Wiemels J., Dosemeci M., Yin S., O'Neill J.P. hprt Mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology 1996, 113:100-105.
36. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Zhang D., Wiemels J., Dosemeci M., Li G., Smith M.T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 2000, 21:55-62.
37. Hayes R.B., Zhang L., Swenberg J.A., Yin S.N., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Wiemels J., Dosemeci M., Li G., Smith M.T. Markers for carcinogenicity among butadiene-polymer workers in China. Chem. Biol. Interact. 2001, 135-136:455-464.
38. Himmelstein M.W., Acquavella J.F., Recio L., Medinsky M.A., Bond J.A. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 1997, 27(1):1-108.
39. Horký J., Vácha J., Znojil V. Comparison of life span of erythrocytes in some inbred strains of mouse using 14C-labelled glycine. Physiol Bohemoslov 1978, 27(3):209-217.
40. Hoyer P.B., Sipes I.G. Development of an animal model for ovotoxicity using 4-vinylcyclohexene: a case study. Birth Defects Res. B 2007, 80:113-125.
41. Johanson G., Filser J.G. PBPK model for butadiene metabolism to epoxides: quantitative species differences in metabolism. Toxicology 1996, 113(1-3):40-47.
42. Kim Y.M., Harrad S., Harrison R.M. Concentrations and sources of VOCs in urban domestic and public microenvironments. Environ. Sci. Technol. 2001, 35(6):997-1004.
43. Kirman C.R., Albertini R.J., Sweeney L.M., Gargas M.L. 1,3-Butadiene I: review of metabolism and the implications to human health risk assessment. Crit. Rev. Toxicol. 2010, 40(Suppl. 1):1-11.
44. Kohn M.C., Melnick R.L. Physiological modeling of butadiene disposition in mice and rats. Chem. Biol. Interact. 2001, 135-136:285-301.
45. Krause R.J., Elfarra A.A. Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch. Biochem. Biophys. 1997, 337(2):176-184.
46. Kreuzer P.E., Kessler W., Welter H.F., Baur C., Filser J.G. Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man. Arch. Toxicol. 1991, 65(1):59-67.
47. Macaluso M., Larson R., Lynch J., Lipton S., Delzell E. Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers. J. Occup. Environ. Hyg. 2004, 1(6):371390.
48. Muhammad F.S., Goode A.K., Kock N.D., Arifin E.A., Cline J.M., Adams M.R., Hoyer P.B., Christian P.J., Isom S., Kaplan J.R., Appt S.E. Effects of 4-vinylcyclohexene diepoxide on peripubertal and adult Sprague-Dawley rats: ovarian, clinical, and pathologic outcomes. Comp. Med. 2009, 59(1):46-59.
49. Science and Decisions Advancing Risk Assessment 2009, NAS, National Academy Press, Washington, DC.
50. NTP toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies) 1984, NTP, National Toxicology Program, Research Triangle Park, NC.
51. NTP, 1993. NTP technical report on the toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies). National Toxicology Program, Research Triangle Park, NC, NTP TR 434.
52. Owen P.E., Glaister J.R., Gaunt I.F., Pullinger D.H. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 1987, 48:407-413.
53. Perbellini L., Princivalle A., Cerpelloni M., Pasini F., Brugnone F. Comparison of breath, blood and urine concentrations in the biomonitoring of environmental exposure to 1,3-butadiene, 2,5-dimethylfuran, and benzene. Int. Arch. Occup. Environ. Health 2003, 76(6):461-466.
54. Pottenger L.H., Becker R.A., Moran E.J., Swenberg J.A. Workshop report: identifying key issues underpinning the selection of linear or non-linear dose-response extrapolation for human health risk assessment of systemic toxicants. Regul. Toxicol. Pharmacol. 2011, 59:503-510.
55. Reiss R. Temporal trends and weekend-weekday differences for benzene and 1,3-butadiene in Houston, Texas. Atmos. Environ. 2006, 40(25):4711-4724.
56. Sax S.L., Bennett D.H., Chilllrud S.N., Kinney P.L., Spengler J.D. Differences in source emission rates of volatile organic compounds in inner-city residences of New York City and Los Angeles. J. Expo. Anal. Environ. Epidemiol. 2004, 14(Suppl. 1):S95-S109.
57. Schmidt U., Loeser E. Species differences in the formation of butadiene monoxide from 1,3-butadiene. Arch. Toxicol. 1985, 57(4):222-225.
58. Seaton M.J., Follansbee M.H., Bond J.A. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 1995, 16(10):2287-2293.
59. Smith T.J., Lin Y.S., Mezzetti M., Bois F.Y., Kelsey K., Ibrahim J. Genetic and dietary factors affecting human metabolism of 1,3-butadiene. Chem. Biol. Interact. 2001, 135-136:407-428.
60. Springer L.N., McAsey M.E., Flaws J.A., et al. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol. Appl. Pharmacol. 1996, 139:394-401.
61. Sweeney L.M., Himmelstein M.W., Gargas M.L. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment. Chem. Biol. Interact. 2001, 135-136:303322.
62. Swenberg J.A., Boysen G., Georgieva N., Bird M.G., Lewis R.J. Future directions in butadiene risk assessment and the role of cross-species internal dosimetry. Chem. Biol. Interact. 2007, 166:78-83.
63. Swenberg J.A., Bordeerat N.K., Boysen G., Carro S., Georgieva N.I., Nakamura J., Troutman J.M., Upton P.B., Albertini R.J., Vacek P.M., Walker V.E., Sram R.J., Goggin M., Tretyakova N. 1,3-Butadiene: biomarkers and application to risk assessment. Chem. Biol. Interact. 2011, 192(1-2):150-154.
64. Thornton-Manning J.R., Dahl A.R., Allen M.L., Bechtold W.E., Griffith W.C., Henderson R.F. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures. Toxicol. Sci. 1998, 41(2):167-173.
65. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., Griffith W.C., Henderson R.F. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation. Toxicology 1997, 123(1-2):125-134.
66. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., Griffith W.C., Pei L., Henderson R.F. Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low level inhalation exposure. Carcinogenesis 1995, 16(11):2875-2878.
67. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., Griffith W.C., Henderson R.F. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 1995, 16(8):1723-1731.
68. USEPA, 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, EPA/600/8-90/066F.
69. USEPA, 1999. Compendium of methods for the determination of toxic organic compounds in ambient air, second ed. Compendium method TO-15. Determination of volatile organic compounds (VOCs) in air collected in specially-prepared canisters and analyzed by gas chromatography/mass spectrometry (GC/MS). US Environmental Protection Agency, Office of Research and Development, Cincinnati, OH, EPA625R96010b.
70. USEPA, 2002. Health assessment of 1,3-butadiene. US Environmental Protection Agency, Washington, DC, EPA600P98001F.
71. User Manual for the " MSW" Multistage Weibull Time-to-Response Model 2010, USEPA, US Environmental Protection Agency.
72. Vainiotalo S., Vaananen V., Vaaranrinta R. Measurement of 16 volatile organic compounds in restaurant air contaminated with environmental tobacco smoke. Environ. Res. 2008, 108(3):280-288.
73. Wallace W.H., Kelsey T.W. Human ovarian reserve from conception to the menopause. PLoS One 2010, 5(1):e8772.
74. Wiencke J.K., Kelsey K.T. Susceptibility to induction of chromosomal damage by metabolites of 1,3-butadiene and its relationship to 'spontaneous' sister chromatid exchange frequencies in human lymphocytes. IARC Sci. Publ. 1993, 265:273.
75. Zhao C., Vodicka P., Sram R.J., Hemminki K. Human DNA adducts of 1,3-butadiene, an important environmental carcinogen. Carcinogenesis 2000, 21:107-111.
76. Zhao C., Vodicka P., Sram R.J., Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 2001, 37:226-230.